167 related articles for article (PubMed ID: 29849196)
21. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
[TBL] [Abstract][Full Text] [Related]
22. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
23. Malignant mesothelioma.
Moore AJ; Parker RJ; Wiggins J
Orphanet J Rare Dis; 2008 Dec; 3():34. PubMed ID: 19099560
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
25. Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?
Agrawal A; Chaddha U; Shojaee S; Maldonado F
Semin Respir Crit Care Med; 2023 Aug; 44(4):462-467. PubMed ID: 37308112
[TBL] [Abstract][Full Text] [Related]
26. Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion.
Foo CT; Paterson A; Duckworth A; Herre J
Chest; 2021 Dec; 160(6):e609-e611. PubMed ID: 34872672
[TBL] [Abstract][Full Text] [Related]
27. [Malignant pleural mesothelioma with an unusual radiologic manifestation].
Jover-Sáenz A; Vilà-Justribó M; Salud-Salvià A; Porcel-Pérez JM; Vicente de Vera P
An Med Interna; 1999 Jul; 16(7):354-6. PubMed ID: 10481335
[TBL] [Abstract][Full Text] [Related]
28. Advances in the biology of malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
Vivero M; Bueno R; Chirieac LR
Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
[TBL] [Abstract][Full Text] [Related]
30. Not everything is what it seems: malignant pleural mesothelioma mimicking lung cancer.
Prisciandaro E; Girelli L; Rampinelli C; Ghioni M; Spaggiari L
Adv Respir Med; 2019; 87(6):265-267. PubMed ID: 31970729
[TBL] [Abstract][Full Text] [Related]
31. [Management of malignant pleural effusion].
Zalcman G; Lechapt E; Bergot E
Rev Prat; 2007 Mar; 57(5):513-23. PubMed ID: 17583136
[TBL] [Abstract][Full Text] [Related]
32. Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time.
Shepherd KE; Oliver LC; Kazemi H
Am J Ind Med; 1989; 16(4):373-83. PubMed ID: 2610210
[TBL] [Abstract][Full Text] [Related]
33. Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.
Augeri S; Capano S; Morone S; Fissolo G; Giacomino A; Peola S; Drace Z; Rapa I; Novello S; Volante M; Righi L; Ferrero E; Ortolan E; Funaro A
Oncotarget; 2018 Apr; 9(32):22785-22801. PubMed ID: 29854315
[TBL] [Abstract][Full Text] [Related]
34. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
Sterman DH; Albelda SM
Respirology; 2005 Jun; 10(3):266-83. PubMed ID: 15955137
[TBL] [Abstract][Full Text] [Related]
35. Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Geltner C; Errhalt P; Baumgartner B; Ambrosch G; Machan B; Eckmayr J; Klikovits T; Hoda MA; Popper H; Klepetko W;
Wien Klin Wochenschr; 2016 Sep; 128(17-18):611-7. PubMed ID: 27619223
[TBL] [Abstract][Full Text] [Related]
36. Pseudo-tumor mimicking indwelling pleural catheter tract metastasis in mesothelioma.
Shrestha RL; Wood BA; Lee YC
J Bronchology Interv Pulmonol; 2014 Oct; 21(4):350-2. PubMed ID: 25321457
[TBL] [Abstract][Full Text] [Related]
37. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
[TBL] [Abstract][Full Text] [Related]
38. [Computed tomography findings of malignant pleural mesothelioma].
Shiota Y; Sato T; Yamaguchi K; Ono T; Kaji M; Niiya H
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Apr; 32(4):309-14. PubMed ID: 8041037
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis.
Tian L; Zeng R; Wang X; Shen C; Lai Y; Wang M; Che G
Oncotarget; 2017 Jul; 8(28):46425-46435. PubMed ID: 28507279
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
